Barclays faces $590 million hit, scrutiny over sales slip-up

A branch of Barclays Bank is seen, in London, Britain, February 23, 2022. REUTERS/Peter Nicholls

LONDON/NEW YORK, March 28 (Reuters) – British bank Barclays faces an estimated 450 million pound ($592 million) loss and regulatory scrutiny for exceeding a U.S. limit on sales of structured products, some of which have surged in popularity since Russia’s invasion of Ukraine.

Barclays (BARC.L) said on Monday that it will have to delay a planned 1 billion pound share buyback as of the loss, which it will have to incur as a result of buying back the securities in question at their original purchase price.

Shares in Barclays fell by as much as 4.5% after it said it had oversold billions of pounds worth of the securities over a period of about a year, overshooting a $20.8 billion limit agreed with United States regulators by $15.2 billion.

The major regulatory blunder is an early embarrassment for C.S. Venkatakrishnan, the newly-appointed chief executive of Barclays, whose previous roles included heading up the bank’s global markets and risk operations.

The products involved include two exchange-traded notes (ETNs) linked to crude oil and market volatility , a source familiar with the matter said. Barclays suspended sales and issuance of both this month. read more

Before sales were suspended, the so-called VXX product had surged in popularity as investors placed bets on volatility as the Ukraine crisis roiled global markets, with the number of shares changing hands daily doubling to 71 million in a month.

Barclays said at the time that capacity issues were to blame and the actions were not linked to the crisis in Ukraine.

The bank said on Monday its best estimate was that the loss on the affected securities would amount to 450 million pounds, cutting its core capital ratio to the middle of its 13-14% target range. The loss estimate did not include tax.

Barclays said it would delay its share buyback until the second quarter of the year as a result.

It said that it had commissioned an independent review, while regulators were conducting inquiries and requesting information from the bank.

Barclays said the securities were registered for sale in August 2019, adding that it would file a new registration with the U.S. Securities and Exchange Commission as soon as practicable.

The wider investment bank had previously proved a stellar performer for Barclays over recent years, helping it to post a record annual profit for 2021. read more

Analysts at Shore Capital said in a note that the bank appeared to be “tripping over its shoelaces”.

While the current share buyback has only been delayed, the error could reduce future capital distributions to shareholders by the bank, the analysts said.

($1 = 0.7604 pounds)

Reporting by Iain Withers in London and Saqib Iqbal Ahmed in New York; Editing by John O’Donnell, Edmund Blair and Alexander Smith

Our Standards: The Thomson Reuters Trust Principles.